Nearly one in three Americans over the age of 60 — roughly 19 million people — take aspirin daily, according to a 2021 study.

For decades, taking a daily low-dose aspirin was a widely accepted practice for preventing heart attacks and strokes. But a ...

The findings showed that P2Y12 inhibitors were more effective than aspirin in reducing the risk of heart attacks and strokes.

Cardiovascular disease is the number one cause of death in the United States, at a cost of about 700,000 lives per year. For ...

The prevalence of daily low-dose aspirin use fell significantly after the American College of Cardiology and the American ...

After guideline changes, aspirin use dropped off overall, even for higher-risk patients in whom it might still be considered.

For decades, aspirin has been the standard preventive treatment for patients with blood vessel disease. After an acute ...

Safe aspirin elimination in patients with HeartMate 3 LVAD reduces bleeding risk, offering key clinical practice insights.

Aspirin use in patients with PI3K-mutated colorectal cancer helped to reduce disease recurrence, highlighting the importance ...

The global aspirin drug market is poised for substantial growth over the next decade, with its value expected to increase ...